Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.21.2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
Revenue        
Revenue
Other revenue 266 888
Total revenue 266 888
Operating expenses:        
Research and development, net of reimbursements 3,631 3,508 7,907 7,659
General and administrative 1,710 1,154 3,428 2,686
Total operating expenses 5,341 4,662 11,335 10,345
Loss from operations (5,075) (4,662) (10,447) (10,345)
Other income:        
Interest income - net 54 37 106 50
Total other income 54 37 106 50
Net loss (5,021) (4,625) (10,341) (10,295)
Deemed dividend for warrant down-round protection provision (1) (1)
Net loss applicable to common stockholders $ (5,021) $ (4,626) $ (10,341) $ (10,296)
Net loss per share of common stock – basic and diluted (in Dollars per share) $ (0.25) $ (0.41) $ (0.54) $ (1.20)
Weighted average shares of common stock outstanding, including outstanding pre-funded warrants– basic and diluted (in Shares) 20,231,278 11,379,345 19,308,487 8,559,385